Furthermore, our results indicate that CLEC3B is significantly downregulated in stage IA and has great diagnostic value for lung cancer at an early stage, since the AUC value of CLEC3B for the diagnosis of stage IA lung cancer patients was approximately 1, which indicates great significance. Here, CLEC3B is linked to lung cancer.